Pharmacy-Based HCV Screening and Care: In-Depth Application

This interactive video module provides in-depth expert perspectives on optimizing HCV service provision in pharmacy settings with an emphasis on screening, linkage to care, key features of HCV treatment, and the importance of drug-drug interaction assessment.
John Faragon, PharmD, BCPS, AAHIVP
Program Director
Michelle T. Martin, PharmD, FCCP, BCPS, BCACP
Released: February 1, 2019 Expiration: No longer available for credit

Related Content

Dr. Arthur Kim reviews EUAs for baricitinib, bamlanivimab, and casirivimab/imdevimab, and NIH Guideline on ivermectin from Clinical Care Options (CCO)

Arthur Kim, MD Released: January 25, 2021

Short video log from Rajesh Gandhi, MD, on the efficacy and safety of COVID-19 vaccines in older persons and persons with HIV

Rajesh T. Gandhi, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 21, 2021 Expired: January 20, 2022

Free expert-authored slides reviewing a patient case and the data on efficacy and safety of authorized COVID-19 vaccines in older persons with HIV

Rajesh T. Gandhi, MD Released: January 21, 2021

Short video log from Rajesh Gandhi, MD, on COVID-19 risk in older persons with HIV and implications for COVID-19 vaccine recommendation

Rajesh T. Gandhi, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 20, 2021 Expired: January 19, 2022
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Gilead Sciences, Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue